Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NovaBay Pharmaceuticals, Inc. (NBY)

0.11   -0.001 (-0.45%) 10-02 21:14
Open: 0.1142 Pre. Close: 0.1105
High: 0.1149 Low: 0.102
Volume: 1,245,302 Market Cap: 6(M)
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.12 - 0.12 0.12 - 0.12
Low: 0.1 - 0.1 0.1 - 0.1
Close: 0.11 - 0.11 0.11 - 0.11

Technical analysis

as of: 2022-09-30 4:30:09 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.22     One year: 0.29
Support: Support1: 0.1    Support2: 0.08
Resistance: Resistance1: 0.19    Resistance2: 0.25
Pivot: 0.13
Moving Average: MA(5): 0.11     MA(20): 0.15
MA(100): 0.22     MA(250): 0.31
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 13.7     %D(3): 13.9
RSI: RSI(14): 20.8
52-week: High: 0.62  Low: 0.1
Average Vol(K): 3-Month: 852 (K)  10-Days: 1,460 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NBY ] has closed above bottom band by 26.9%. Bollinger Bands are 6.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 30 Sep 2022
Is NovaBay Pharmaceuticals, Inc. (NBY) Stock Worth a Buy Friday? - InvestorsObserver

Fri, 30 Sep 2022
IN BRIEF: Silverwood Brands buys nail brand NBY London - Morningstar

Fri, 23 Sep 2022
Canby improves to 6-0 in conference | News, Sports, Jobs - Marshall Independent

Thu, 22 Sep 2022
How Will the Market React to NovaBay Pharmaceuticals, Inc. (NBY) Stock Getting a Bearish Rating - InvestorsObserver

Tue, 13 Sep 2022
NioBay Metals begins drilling following significant prospecting results on Crevier - Junior Mining Network

Mon, 12 Sep 2022
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Showcase DERMAdoctor's Eczema Balm on Return QVC® Appearance - Business Wire

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 45 (M)
Shares Float 35 (M)
% Held by Insiders 21.1 (%)
% Held by Institutions 2.6 (%)
Shares Short 2,080 (K)
Shares Short P.Month 1,940 (K)

Stock Financials

EPS -0.18
EPS Est Next Qtl -0.03
EPS Est This Year -0.47
EPS Est Next Year -0.1
Book Value (p.s.) 0.2
Profit Margin (%) -96.8
Operating Margin (%) -96.9
Return on Assets (ttm) -31.7
Return on Equity (ttm) -63.9
Qtrly Rev. Growth -15.2
Gross Profit (p.s.) 0.13
Sales Per Share 0.17
EBITDA (p.s.) -0.17
Qtrly Earnings Growth 0
Operating Cash Flow -6 (M)
Levered Free Cash Flow -3 (M)

Stock Valuations

PE Ratio -0.64
PEG Ratio 0
Price to Book value 0.52
Price to Sales 0.64
Price to Cash Flow -0.79

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.